Expression and structural-functional alterations of α-1-acid glycoprotein at the pathological state

Biopolymers and Cell

Volumn 26, Issue 4, 2010, Pages 265-272

  Stekleneva, N I ^a   Shevtsova, A I ^a   Brazaluk, O Z ^a   Kulinich, A O ^a  

^a Dnipropetrovsk State Medical Academy   (Ukraine)

Author keywords

A acid glycoprotein; Glycosylation; Inflammation; Oncopathology

Indexed keywords

OROSOMUCOID;

ARTICLE; FUCOSYLATION; INFLAMMATION; PROTEIN FUNCTION; PROTEIN STRUCTURE; SIALYLATION;

EID: 77955627651     PISSN: 02337657     EISSN: 19936842     Source Type: Journal    
DOI: 10.7124/bc.00015E     Document Type: Article

References (39)

1. Kopecky V., Ettrich R., Hofbauerov K., Baumruka V. Structure of human a1-acid glycoprotein and its high-affinity bin-ding site. Biochem. Biophys. Res. Communs. 2003. 300, N 1. P. 41-46.
2. Nishi K., Komine Y., Fukunaga N., Maruyama T., Suenaga A., Otagiri M. Involvement of disulfide bonds and histidine 172 in a unique beta-sheet to alpha-helix transition of alpha 1-acid glycoprotein at the biomembrane interface. Proteins. 2006. 63, N 3. P. 611-620.
3. Fournier T., Medjoubi N. N., Porquet D. Alpha-1-acid glycoprotein. Biochim. Biophys. Acta. 2000. 1482, N 1-2. P. 157-171.
4. Theilgaard-Monch K., Jacobsen L., Rasmussen T. Highly glycosylated a-acid glycoprotein is synthesized in myelo-cytes, stored in secondary granules, and released by activated neutrophils. J. Leukoc. Biol. 2005. 78, N 2. P. 462-470.
5. Nakamura H., Yuasa I., Umetsu, K., Nakagawa, M., Nanba, E., Kimura K. The rearrangement of the human alpha(1)-acid glycoprotein/orosomucoid gene: Evidence for tandemly triplicated genes consisting of two AGP1 and one AGP2. Biochem. Biophys. Res. Communs. 2000. 276, N 2. P. 779-784.
6. Logdberg L., Wester L. Immunocalins: a lipocalin subfamily that modulates immune and inflammatory responses. Biochim. Biophys. Acta. 2000. 1482, N 1-2. P. 284-297.
7. Azuma Y., Murata M., Matsumoto K. Alteration of sugar chains on a1-acid glycoprotein secreted following cytokine stimulation of HuH-7 cells in vitro. Clin. Chim. Acta. 2000. 294, N 1-2. P. 93-103.
8. Kishino S., Nomura A., Itoh S., Nakagawa T., Takekuma Y., Sugawara M., Furukawa M., Todo S., Miyazaki K. Ageand gender-related differences in carbohydrate concentrations of alpha1-acid glycoprotein variants and the effects of glycoforms on their drug-binding capacities. Eur. J. Clin. Pharmacol. 2002. 58, N 9. P. 621-628.
9. Orczyk-Pawiowicz M., Hirnle L., Katnik-Prastowska I. Alterations of N-glycan branching and expression of sialic acid on amniotic fluid alpha-1-acid glycoprotein derived from second and third trimesters of normal and prolonged pregnancies. Clin. Chim. Acta. 2006. 367, N 1-2. P. 86-92
10. Stumpe M., Miller C., Morton S., Bell G., Watson G. Highperformance liquid chromatography determination of alpha1-acid glycoprotein in small volumes of plasma from neonates. J. Chromatogr. Analyt. Technol. Biomed. Life Sci. 2006. 831, N 1-2. P. 81-84.
11. Israili Z. H., Dayton P. G. Human a1-glycoprotein and its interactions with drugs. Drug Metab. Rev. 2001. 33, N 2. P. 161-235.
12. Boffito M., Katiusha S., Raiteri R. 1-acid glycoprotein levels in human immunodeficiency virus-infected subjects on anti-retroviral regimens. Am. Soc. Pharmacol. Exp. Therap. 2002. 30, N 7. P. 859-860.
13. Jiang H., Guan G., Zhang R., Liu G., Liu H., Hou X., Cheng J. Increased urinary excretion of orosomucoid is a risk predictor of diabetic nephropathy. Nephrology (Carlton). 2009. 14, N 3. P. 332-337.
14. Irmak S., Oliveira-Ferrer L., Singer B., Ergun S., Tilki D. Pro-angiogenic properties of orosomucoid (ORM). Exp.Cell Res. 2009. 315, N 18. P. 3201-3209.
15. Hochepied T., Berger F.G., Baumann H., Libert C. Alpha(1) acid glycoprotein: an acute phase protein with inflammatory and immunomodulating properties. Cytokine Growth Factor Rev. 2003. 14, N 1. P. 25-34.
16. Shemyakin I. G., Pukhalsky A. L., Stepanshina V. N., Shmarina G. V., Aleshkin V. A., Afanas’ev S. S. Preventive and the-rapeutic effects of alpha-acid glycoprotein in mice infected with B. anthracis. Bull. Exp. Biol. Med. 2005. 140, N 4. P. 439-444.
17. Harley J., Roberts R., Joyce P., Mulder R., Luty S., Frampton C., Kennedy M. Orosomucoid influences the response to anti-depressants in major depressive disorder. J. Psychopharm. 2009. 10, N 4. P. 101-105.
18. Nakano M., Higo D., Arai E., Nakagawa T., Kakehi K., Taniguchi N., Kondo A. Capillary electrophoresis-electrospray ionization mass spectrometry for rapid and sensitive N-glycan analysis of glycoproteins as 9-fluorenylmethyl derivatives. Glycobiology. 2009. 19, N 2. P. 135-143.
19. Higai K., Aoki Y., Azuma Y., Matsumoto K. Glycosylation of site-specific glycans of alpha1-acid glycoprotein and alterations in acute and chronic inflammation. Biochim. Biophys. Acta. 2005. 1725, N 1. P. 128-135.
20. Lowe J. B. Glycan-dependent leukocyte adhesion and recruitment in inflammation. Curr. Opin. Cell Biol. 2003. 15, N 5. P. 531-538
21. Hashimoto S., Asao T., Takahashi J., Yagihashi Y., Nishimura T., Saniabadi A. R., Poland D. C., van Dijk W., Kuwano H., Kochibe N., Yazawa S. Alpha1-acid glycoprotein fucosylation as a marker of carcinoma progression and prognosis. Cancer. 2004. 101, N 12. P. 2825-2836.
22. Poland D. C., Vallejo J., Niessen W. Activated human PMN synthesize and release a strongly fucosylated glycoform of alpha-1-acid glycoprotein, which is transiently deposited in human myocardial infarction. J. Leukoc. Biol. 2005. 78, N 2. P. 453-461.
23. Kratz E., Poland D. C., van Dijk W., Katnik-Prastowska I. Alterations of branching and differential expression of sialic acid on alpha-1-acid glycoprotein in human seminal plasma. Clin. Chim. Acta. 2003. 331, N 1-2. P. 87-95.
24. Van Den Heuvel M., Poland D. C., De Graaff C., Hoefsmit E., Postmus P., Beelen R., Van Dijk W. The degree of branching of the glycans of alpha(1)-acid glycoprotein in asthma. A correlation with lung function and inflammatory parameters. Am. J. Respir. Crit. Care Med. 2000. 161, N 6. Ð. 1972-1978.
25. Poland D., Schalkwijk G., Stehouwer D. Increased alpha3fucosylation of alpha 1-acid glycoprotein in Type 1 diabetic patients is related to vascular function. Glycoconj. J. 2001. 18, N 3. P. 261-268.
26. Olewicz-Gawlik A., Korczowska-Kacka I., Jacki J., Klama K., Hrycaj P. Fucosylation of serum alpha1-acid glycoprotein in rheumatoid arthritis patients treated with infliximab. Clin. Rheumatol. 2007. 26, N 10. P. 1679-1684.
27. Stekleneva N., Brazaluk O., Lytvyn K., Suremenco M., Shevtsova A. Content and glycosylation of a-1-acid glycoprotein in acute, chronic viral hepatitis and oncopathology. Med. Chem. 2006. 8, N 3. P. 119-121.
28. French D., Watson J., McCahill B., Taggart I., Smith K. A preliminary evaluation of the functional significance of al-pha-1-acid glycoprotein glycosylation on wound healing. Biomed. Chromatogr. 2002. 16, N 6. P. 412-419.
29. Romao J., Haiashi R., Elias M. Positive acute-phase inflam-matory markers in different stages of chronic kidney disease. Am. J. Nephrol. 2006. 26, N 1. P. 59-66.
30. Chandrasekaran E., Chawda R., Rhodes J., Xia J., Piskorz C., Matta K. Human lung adenocarcinoma 1,3/4-L-fucosyl-transferase displays two molecular forms, high substrate affinity for clustered sialyl LacNAc type 1 units as well as mucin core 2 sialyl LacNAc type 2 unit and novel 1,2-L-fucosylating activity. Glycobiology. 2001. 11, N 5. P. 353-363.
31. Croce M., Salice C., Lacunza E., Segal-Eiras A. Alpha 1-acid glycoprotein (AGP): a possible carrier of sialyl lewis X (slewis X) antigen in colorectal carcinoma. Histol. Histopathol. 2005. 20, N 1. P. 91-97.
32. Song E., Kim K., Kim Y. Elevation of serum asialo-alpha acid glycoprotein concentration in patients with hepatic cirrhosis and hepatocellular carcinoma as measured by antibody-lectin sandwich assay. Hepatol. Res. 2003. 26, N 4. P. 311-317.
33. Lee E., Kang J., Kim K., Chung T., Kim J., Yoon Y., Lee G., Kwon H., Kim J. W., Kim H., Song E. Development of a rapid, immunochromatographic strip test for serum asialo a1-acid glycoprotein in patients with hepatic disease. J. Immunol. Meth. 2006. 308, N 1-2. P. 116-123.
34. Stekleneva N., Nikolaenko T., Shevtsova A., Brazaluk O., Lytvyn K. Microheterogeneity of alpha acid glycoprotein in neo-plasm and inflammatory processes. Oncology. 2007. 9, N 2. P. 101-104.
35. Rene B., Olivares R., Berille J., Chaikin P., Vivier N., Hammershaimb L., Rhodes G., Rigas J. a-acid glycoprotein as an independent predictor for treatment effects and a prognostic factor of survival in patients with non-small cell lung cancer treated with docetaxel. Clin. Cancer Res. 2003. 9, N 3. P. 1077-1082.
36. Zsila F., Fitos I., Bencze G., Keri G., Orfi L. Determination of human serum alpha-1-acid glycoprotein and albumin binding of various marketed and preclinical kinase inhibitors. Curr. Med. Chem. 2009. 16, N 16. P. 1964-1977.
37. Comunale M., Lowman M., Long R., Krakover J., Seeholzer S., Evans A., Hann L., Block M., Mehta S. Proteomic analysis of serum associated fucosylated glycoproteins in the development of primary hepatocellular carcinoma. J. Proteome Res. 2006. 5, N 2. P. 308-315.
38. Kossowska B., Ferens-Sieczkowska M., Gancarz R., Passowicz-Muszyñska E., Jankowska R. Fucosylation of serum gly-coproteins in lung cancer patients. Clin. Chem. Lab. Med. 2005. 43, N 4. P. 361-369.
39. Pukhal’skii A. L., Shmarina G. V., Kalashnikova E. A., Shiyan S. D., Kokarovtseva S. N., Pukhal’skaya D. A., Bovin N. V.Effect of semisynthetic analog of alpha-acid glycoprotein on immunomodulatory and antiinflammatory activity of natural glycoprotein. Bull. Exp. Biol. Med. 2000. 129, N 5. P. 480-483.